Global X S&P Biotech ETF (CURE) News Today Add Share Share Headlines Stock AnalysisBuy This Stock CURE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period The long game: ASX ETFs to target amidst an ageing populationJuly 8, 2025 | fool.com.auGlobal X S&P 500 U.S. Market Leaders TOP 50 ETFApril 26, 2025 | markets.businessinsider.comTrump health policy uncertainty sends biotech sector into deeper slumpApril 14, 2025 | reuters.comPrivate Equity, Venture Capital Flows To Biotechnology Lowest Since 2019February 19, 2025 | seekingalpha.comXBI: Biotech ETF Is A Must HaveOctober 25, 2024 | seekingalpha.comRisky Loans Get the ETF TreatmentOctober 17, 2024 | wsj.comHHZVF Global X S&P/TSX Capped Energy Index Corporate Class ETFSeptember 25, 2024 | seekingalpha.comThis GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its MoneyAugust 25, 2024 | msn.comGlobal X China Biotech UCITS ETF USD Accumulating (CBIO)August 7, 2024 | investing.comModerna, Inc.: Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical TrialsMarch 28, 2024 | finanznachrichten.deXBI: Biotech Is A Strong Buy As M&A Activity Picks Up (Rating Upgrade)March 20, 2024 | seekingalpha.comBiotech group backs anti-China bill; part ways with WuXi AppTecMarch 14, 2024 | msn.comX-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ TransplantationMarch 13, 2024 | finance.yahoo.comKrystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesFebruary 26, 2024 | markets.businessinsider.comSaudi Aramco and FT accused of running misleading ‘sustainable’ fuel advertsFebruary 22, 2024 | finance.yahoo.comLIXTE Biotechnology Shares Rise 14% After First Patient Dosed in LB-100 TrialJanuary 29, 2024 | marketwatch.comHuman Microbiome Therapeutics Market Size and Share Expected to Cross USD 3,917.01 Million By 2032, at 22.7% CAGR: Polaris Market ResearchJanuary 11, 2024 | finance.yahoo.comU.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISSJanuary 11, 2024 | finance.yahoo.comGlobal $16.2B Research Antibodies & Reagents Market by Product, Technology, Application, End User & Region - Forecast to 2028January 10, 2024 | finance.yahoo.comBone Wax Market to Reach USD 107.8 billion by 2031, Rising at a CAGR of 3.3% | Transparency Market Research, Inc.January 10, 2024 | finance.yahoo.comDefence's AccuTOX(R) Impairs Lung Cancer GrowthJanuary 10, 2024 | finance.yahoo.comGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030January 9, 2024 | markets.businessinsider.comEli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024January 5, 2024 | msn.comBiotechtech Stocks Find a Cure: M&ADecember 29, 2023 | msn.comThese 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche BankDecember 17, 2023 | markets.businessinsider.comCheck out the renovations at the Kohler Waters SpaDecember 13, 2023 | msn.comHere's what to expect from Burning Rock Biotech's earnings reportNovember 29, 2023 | markets.businessinsider.comNew ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of tradeNovember 22, 2023 | msn.com7 Underappreciated Biotech Stocks to Pick Up on the CheapNovember 9, 2023 | markets.businessinsider.comRobust Financial Performance and Promising Gene Therapy Pipeline Bolster Krystal Biotech’s Buy RatingNovember 7, 2023 | markets.businessinsider.comCidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNovember 2, 2023 | markets.businessinsider.comIntellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy?October 28, 2023 | fool.comGlobal X ETFs Ranked Among Best Places to Work in New York by Crain's New York BusinessSeptember 28, 2023 | benzinga.com5 Best Pharma ETFsSeptember 12, 2023 | insidermonkey.comKrystal Biotech (KRYS) Receives a New Rating from Berenberg BankSeptember 6, 2023 | markets.businessinsider.comDiverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201August 30, 2023 | benzinga.comAxcella Therapeutics Gets Patent for Long Covid TreatmentAugust 30, 2023 | marketwatch.comBetter Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatmentJuly 10, 2023 | msn.comThese ETFs Let You Maximize Your Exposure To The Biotech Industry's Performance – Whether Positive Or InverseMarch 24, 2023 | benzinga.comETFs to Play Biotech M&AMarch 19, 2023 | thestreet.comGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM), Earnings Estimates, EPS, and RevenueMarch 7, 2023 | benzinga.comGlobal X Launches 2 ESG-Focused Covered Call ETFsFebruary 24, 2023 | nasdaq.com7 Cheap But Risky Biotech StocksJanuary 18, 2023 | barrons.comUpdate on Acticor Biotech's clinical developments with glenzocimab in the treatment of cardiovascular emergenciesJanuary 11, 2023 | benzinga.comGlobal Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGRJanuary 9, 2023 | benzinga.comBank of America just added these biotech stocks to its list of first-quarter picksJanuary 8, 2023 | cnbc.comGlobal X Funds - Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)January 7, 2023 | fool.com3 Advancements in Biotech Investors Should Look Out for in 2023January 5, 2023 | nasdaq.comGlobal X S&P Biotech ETF (CURE.AX)October 17, 2022 | finance.yahoo.comBIOTECH IS ONE OF THE FIRST TO USE REGULATION CROWDFUNDING TO HELP FIND A CURE FOR CHEMICAL ADDICTION.September 16, 2022 | finance.yahoo.com Get Global X S&P Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter. Email Address CURE Media Mentions By Week CURE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CURE News Sentiment▼0.000.62▲Average News Sentiment CURE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CURE Articles This Week▼00▲CURE Articles Average Week Get Global X S&P Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CURE) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
